Healing & Tissue Repair · Research deep dive
ARA-290: the cited literature
Every study referenced in the ARA-290 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, ARA-290 is studied at 2 mg – 4 mg per administration, typically once daily for 28 days. The reference walkthrough below maps each citation to what it actually showed.
References covered
ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss
Mol. Med., 2014
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for ARA-290.